About Gelato #33
G33HybridCured properly, flowers of Gelato have a predominant smell of pungent citrus, compliments of fruity parent strain Sunset Sherbert.
Bred by Sherbinskis
Gelato is a hybrid crossed from taste-engineered parents Thin Mint Girl Scout Cookies and fruity indica Sunset Sherbert. With a balanced, mellow high and a universally appealing flavor profile, this is a great strain for social use. San Francisco creators Cookie Fam Genetics have released multiple numbered phenotypes of Gelato - phenotype #33 has picked up the nickname Larry Bird in reference to the legendary player’s jersey number. This strain has an indica-leaning high and carries a THC composition that ranges from 20% to 25%.
Gelato’s buds tend to be small but they have the thick and dense structure characteristic of many indica varieties. This is a strain with immediate visual appeal: bright orange pistils stand out against forest green leaves that are accented by shades of deep purple. The purple hues come about when high concentrations of pigments called anthocyanins are stimulated by cold weather in the vegetative stage. Although the buds themselves are sticky, short stalks on the trichomes mean that this strain has a less frosty appearance than many others. Cured properly, flowers of Gelato have a predominant smell of pungent citrus, compliments of fruity parent strain Sunset Sherbert. Notes of yeast and dough can be detected as well.
Grinding up or breaking apart the flowers gives off a more herbal, earthy profile.
Description provided by Wikileaf.
Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About PhCann International B.V.
PharmaCann International is a leading company in the field of pharmaceutical cannabis, operating in accordance with EU GMP standards, with vertically integrated operations including, cloning, cultivating, cannabinoid API extraction, and pharmaceutical production and packaging.
Since inception, PharmaCann International has strive in its corporate social responsibility strategy to provide patients in need of products containing high-quality cannabinoids of natural origin and to disseminate knowledge about the therapeutic use of cannabinoids.
PharmaCann’s mission is make available a wide range of medical cannabis preparations for patients, who can benefit clinically, at the right time, at the right cost and for the right indication. Quality Control
PharmaCann operates in accordance with the highest standards, including GACP, GLP, GDP and ISO 9001, ISO 14001, ISO 27001 ISO 17025. and has a world-class laboratory for testing cannabinoids and research and development.
The Company’s European pharmaceutical cannabis facility has incorporated the latest growing, extraction and packaging technology as well established scientific methodologies to develop targeted medical cannabis products.
nyskholdings.com